Literature DB >> 8823946

Hybrid modeling, HMM/NN architectures, and protein applications.

P Baldi1, Y Chauvin.   

Abstract

We describe a hybrid modeling approach where the parameters of a mode are calculated and modulated by another model, typically a neural network (NN), to avoid both overfitting and underfitting. We develop the approach for the case of Hidden Markov Models (HMMs), by deriving a class of hybrid HMM/NN architectures. These architectures can be trained with unified algorithms that blend HMM dynamic programming with NN backpropagation. In the case of complex data, mixtures of HMMs or modulated HMMs must be used. NNs can then be applied both to the parameters of each single HMM, and to the switching or modulatation of the models, as a function of input or context. Hybrid HMM/NN architectures provide a flexible NN parameterization for the control of model structure and complexity. At the same time, they can capture distributions that, in practice, are inaccessible to single HMMs. The HMM/NN hybrid approach is tested, in its simplest form, by constructing a model of the immunoglobulin protein family. A hybrid model is trained, and a multiple alignment derived, with less than a fourth of the number of parameters used with previous single HMMs.

Mesh:

Substances:

Year:  1996        PMID: 8823946     DOI: 10.1162/neco.1996.8.7.1541

Source DB:  PubMed          Journal:  Neural Comput        ISSN: 0899-7667            Impact factor:   2.026


  2 in total

1.  Computational prediction and experimental verification of new MAP kinase docking sites and substrates including Gli transcription factors.

Authors:  Thomas C Whisenant; David T Ho; Ryan W Benz; Jeffrey S Rogers; Robyn M Kaake; Elizabeth A Gordon; Lan Huang; Pierre Baldi; Lee Bardwell
Journal:  PLoS Comput Biol       Date:  2010-08-26       Impact factor: 4.475

2.  Improved alignment of nucleosome DNA sequences using a mixture model.

Authors:  Ji-Ping Z Wang; Jonathan Widom
Journal:  Nucleic Acids Res       Date:  2005-12-09       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.